Sonoma Pharmaceuticals to Effect 1-for-20 Reverse Stock Split

07:21 AM EDT, 08/28/2024 (MT Newswires) -- Sonoma Pharmaceuticals (SNOA) said Wednesday it will effect a 1-for-20 reverse split of its common shares this Thursday.

Trading on an adjusted basis will begin Friday on the Nasdaq Capital Market, the company said.

The reverse stock split is intended to increase the per-share trading price of the company to satisfy Nasdaq's $1 minimum bid price requirement for continued listing.

Price: 0.1906, Change: -0.03, Percent Change: -12.13